Clean Science Q1FY27 results: dividend, new unit approved

What Clean Science reported for Q1FY27

Clean Science & Technology Ltd has reported a mixed set of numbers for the quarter ended June 30, 2026 (Q1FY27), with a year-on-year dip in standalone profit and revenue but stronger consolidated growth. The company said its Board of Directors approved the unaudited standalone and consolidated financial results on August 1, 2026. The results were subject to a limited review by its statutory auditors, Price Waterhouse Chartered Accountants LLP. Alongside the financials, the Board also cleared a final dividend for FY2025-26 and approved corporate actions including a board appointment and a new overseas subsidiary.

Key headline numbers at a glance

On a standalone basis, net profit after tax fell 4.3% year-on-year to ₹73.29 crore from ₹76.57 crore. Standalone revenue from operations declined 5.8% to ₹207.10 crore from ₹219.91 crore. On a consolidated basis, net profit after tax increased 4.7% to ₹73.35 crore from ₹70.06 crore, while consolidated revenue from operations rose 10.5% to ₹268.43 crore from ₹242.87 crore. Earnings per share (basic) on a standalone basis was ₹6.90, compared with ₹7.21 a year ago. Consolidated basic EPS was ₹6.90 versus ₹6.59 in Q1FY26.

Standalone performance: revenue and profit both lower

The standalone numbers showed a year-on-year contraction in both revenue and profitability for the quarter. Revenue from operations fell to ₹207.10 crore from ₹219.91 crore, a decline of 5.8%. Profit before tax came in at ₹97.52 crore compared with ₹102.42 crore, down 4.8%. Net profit after tax was ₹73.29 crore versus ₹76.57 crore, down 4.3%. The basic EPS of ₹6.90 mirrored the decline in profit on a per-share basis compared with ₹7.21 in Q1FY26.

Consolidated performance: revenue growth offsets the contrast

In contrast to the standalone trend, the consolidated financials showed stronger year-on-year growth. Consolidated revenue from operations increased to ₹268.43 crore from ₹242.87 crore, up 10.5%. Profit before tax was ₹97.55 crore, compared with ₹94.55 crore in Q1FY26, up 3.2%. Net profit after tax rose to ₹73.35 crore from ₹70.06 crore, an increase of 4.7%. Basic EPS improved to ₹6.90 from ₹6.59.

Why standalone and consolidated numbers diverged

The quarter underlined a common feature in Indian listed companies with subsidiaries: standalone performance can differ materially from consolidated performance. Standalone financials reflect the parent entity’s operations, while consolidated results include subsidiaries and other consolidated entities. In this quarter, the consolidated revenue line grew even as standalone revenue declined. The data released by the company shows that the improvement was visible primarily at the top line, with consolidated revenue growth outpacing profit growth.

Board approvals: results, final dividend, and governance changes

The company said the Board approved the unaudited results on August 1, 2026. It also declared a final dividend for FY2025-26, with the payment scheduled for September 30, 2026. The dividend will be paid to shareholders registered as of September 5, 2026, as per the company’s stated record date.

On the governance side, the Board co-opted Krishnakumar Satyanarain Saboo as an Additional Director. The company also sanctioned a new subsidiary in the Netherlands for specialty chemical distribution, indicating an intent to strengthen overseas distribution capabilities through a dedicated entity.

Strategic supply agreement with Kemin Industries

Separately, the company said it has secured a five-year strategic supply agreement with Kemin Industries. As described, the arrangement is to provide key ingredients for the food and feed industry. The disclosed information focused on the duration and the broad end-use segment, without detailing volumes, pricing, or revenue contribution.

Trading window closure around the result cycle

Ahead of the results, Clean Science had informed exchanges that its Board would meet on August 1, 2026, to consider and approve the Q1FY27 unaudited results. The company also said the trading window for designated persons and their immediate relatives was closed from July 1, 2026. The window is scheduled to reopen 48 hours after the financial results announcement, consistent with standard compliance practices.

Summary table of reported financial metrics

All figures below are as reported by the company, converted to ₹ crore for comparability.

Market impact and what investors typically track next

The disclosures in this update were centred on the quarter’s numbers and Board decisions, rather than forward guidance. Investors tracking the stock after the filing typically focus on the gap between standalone and consolidated revenue trends, the movement in profit before tax and net profit, and any additional disclosures that may follow regarding the Netherlands subsidiary’s operating timeline. The final dividend timeline and record date are also relevant for shareholders planning for payout eligibility.

Conclusion

Clean Science’s Q1FY27 update combined weaker standalone performance with stronger consolidated growth, alongside Board actions on a final dividend, an Additional Director appointment, and a Netherlands subsidiary for specialty chemical distribution. The company has also disclosed a five-year supply agreement with Kemin Industries. The next operational updates, if any, are likely to come through subsequent exchange filings and company communications tied to execution of these approvals and business arrangements.